ArticleFrontiers in immunology2020

Therapeutic Potential of Targeting Malt1-Dependent TCR Downstream Signaling to Promote the Survival of MHC-Mismatched Allografts.

Lerisa Govender et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.